- Home
- WIA vs INBX Comparison
WIA vs INBX Comparison
Compare WIA & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- INBX
- Stock Information
- Founded
- WIA 2003
- INBX 2010
- Country
- WIA United States
- INBX United States
- Employees
- WIA N/A
- INBX N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- WIA Finance
- INBX Health Care
- Exchange
- WIA Nasdaq
- INBX Nasdaq
- Market Cap
- WIA 190.7M
- INBX 178.5M
- IPO Year
- WIA N/A
- INBX 2020
- Fundamental
- Price
- WIA $8.33
- INBX $15.69
- Analyst Decision
- WIA
- INBX Hold
- Analyst Count
- WIA 0
- INBX 1
- Target Price
- WIA N/A
- INBX N/A
- AVG Volume (30 Days)
- WIA 39.2K
- INBX 71.4K
- Earning Date
- WIA 01-01-0001
- INBX 08-12-2025
- Dividend Yield
- WIA 12.29%
- INBX N/A
- EPS Growth
- WIA N/A
- INBX N/A
- EPS
- WIA N/A
- INBX 111.58
- Revenue
- WIA N/A
- INBX $200,000.00
- Revenue This Year
- WIA N/A
- INBX N/A
- Revenue Next Year
- WIA N/A
- INBX N/A
- P/E Ratio
- WIA N/A
- INBX $0.13
- Revenue Growth
- WIA N/A
- INBX N/A
- 52 Week Low
- WIA $7.56
- INBX $10.80
- 52 Week High
- WIA $8.91
- INBX $17.79
- Technical
- Relative Strength Index (RSI)
- WIA 68.59
- INBX 66.26
- Support Level
- WIA $8.19
- INBX $14.19
- Resistance Level
- WIA $8.21
- INBX $15.67
- Average True Range (ATR)
- WIA 0.06
- INBX 0.84
- MACD
- WIA 0.02
- INBX 0.13
- Stochastic Oscillator
- WIA 100.00
- INBX 96.27
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.